Determining Methods of Collaborative, Realistic, and Cost Effective Supply Timelines. Fatima Zaidi Clinical Trial Supply New England

Size: px
Start display at page:

Download "Determining Methods of Collaborative, Realistic, and Cost Effective Supply Timelines. Fatima Zaidi Clinical Trial Supply New England"

Transcription

1 Determining Methods of Collaborative, Realistic, and Cost Effective Fatima Zaidi Clinical Trial Supply New England

2 Drug Development and Clinical Supply Annual supply chain spending for drugs under clinical trials can be substantial e.g., accounting for 20% or more of company s R&D spending Fleischhacker, A., Y. Zhao (2007). Planning for Demand Failure: A Dynamic Lot Size Model for Clinical Trial Supply Chains 2

3 Clinical Supply Planning Management of complex program with multinational regulations, functions, activities, and interactions 3

4 Challenges in Clinical Supply Planning Complex distribution network Variable enrollment rate Patient Drop-outs Expiration dating Randomization Stratification Bulk availability constraints Weight based dosage Multiple dose levels 4

5 Clinical Supply Optimization Minimize Risk Insufficient Stock Minimize Cost Manfg./Pckg/ Distribution Late Resupply Waste/Rush orders Insufficient overage Workload 5

6 Project Management Approach for Clinical Supply Planning: Getting right inventory, to right place, at right time 6

7 Factors Ensuring Optimization in Clinical Supply Planning Team Structure Processes Tools Systems Communication Determining Methods of Collaborative, Realistic, and Cost Effective 7

8 Team Structure Industry trends in clinical supply team structure(s) 8

9 Industry trends in clinical supply team structure(s) For productive positioning of clinical supply teams Larger CTS groups tend to be more specialized by activities: - Demand planning - Clinical trial supply set-up (packaging design, label approval, etc.) - Inventory management - IVR set-up - Outsourcing - Logistics Increasing trend in CTS is to take a project management approach: - Dedicated CTS Project Manager (PM) assigned to clinical study - CTS PM handles all activities from start to finish (demand planning, packaging/labeling, vendor management) - CTS Program Manager assigned to coordinate/plan with multiple CTS PMs 9

10 Efficient Processes and Systems Lean processes and integrated systems Optimizing Processes Develop processes and tools appropriate for department and company size. Create process maps, assess gaps, and identify bottle necks. Remove bottle necks Integrating disparate systems used by vendors and sponsors Identify system/technology to integrate the systems: - Cost of system implementation - Time to build and validate the integrated system Single messaging standard across vendor and sponsor system (Extensible Markup Language XML) Determining Methods of Collaborative, Realistic and Cost Effective 10

11 Clinical Supply Systems Used across Biopharmaceutical Industry Software system Vendor Forecasting COMPASS Almac Optimizer/Tc Visualize Smart Supplies Bio Clinica CLINapps Labeling/Inventory Management Clinicopia Aptuit SAP CTSM add on POMS CMS CTSS, ERP system Freezerworks Lodestone, Inc. Honeywell Rockwell Automation Freezerworks IVR/IWR Management Almac, Cenduit, Perceptive/ClinPhone, PPD Prelude Vision United BioSource Corp. 11

12 Activity Planning Tool Standard lead times for clinical supply activities Activities Lead times* Demand planning (drug substance) 9-12 months Study supply agreement (b/w clinical and CTS) Demand planning bulk drug Forecasting distribution scenario analysis, initial supply, resupply quantities Vendor selection (RFP, Contracts, Timelines) 9 months 6-9 months 6 months 6 months - Packaging distribution vendor 6 months - IVR/IWR vendor (design build, UAT, launch 6 months Label approval Label translations Booklet label printing Packaging/Labeling, Import permits Distribution ( to depots) IVR UAT/ launch 6-7 months 6 months 6 months 3-4 months 3 months 1 month Distribution to sites 1-2 weeks * - Lead times are from First Patient in (FPI) 20 March

13 Cost - Develop supply budget during design phase Start the race with finish line in sight Drug product cost - API - Manufacturing Study Parameters - Number of subjects, sites, countries - Global site distribution - Dosing, blinding, enrollment forecast Packaging & Labeling - blister/bottle - number of packaging campaigns, product expiry date - booklet label/number of languages - storage and distribution Other - IVR - expiry date management PLEASE INSERT Presentation title 13

14 Cost - Developing Initial Study Budget Example (hypothetical) Study Parameters/Specifications Cost Total Number of subjects; sites; and countries 500; 100; 8 Study duration, expiry date 3 years, 24 months Number of subject, visits, dosing Primary packaging (100 count bottles) with booklet label $ Number of packaging campaigns 3 12, 20 mg 100 mg flexible dose Packaging cost (total number of bottles, 3 packaging campaigns) $ , Storage cost (3 depots) per year $10, , Distribution cost (per shipment, and return) $100.00, $ , Other, export permits, label translation $ , Expiry date management, relabeling Variable 10, IVR/IWR (with returns module) $350, Total 740,

15 Communication, Collaboration, and Transparency Between Supply and Clinical Development Encourage involvement of supply personnel at the stage of protocol development to ensure feasibility of projected timelines. Early involvement of supply personnel during protocol development phase Robust activity and timeline planning Good communication, and frequent meetings with involved parties during study design and trial phase. (Clinical supply, Clinical development, Manufacturing, Analytical, Vendors) Cross functional coordination Determining Methods of Collaborative, Realistic, and Cost Effective 15

16 Other Programs/Tools To achieve clinical supply optimization Technical training programs in CTS E.g., 3 month apprenticeship with rotation(s) in manufacturing, analytical, packaging & labeling, distribution, shadowing program(s). Cross-functional trainings Within R&D organization to enhance alignment on processes and lead times Establishing KPIs/metrics to measure and improve performance: - On time delivery, Waste reduction People development Career ladder within CTS Ongoing training, Incentives PLEASE INSERT Presentation title 16

17 Questions/Comments 17

INTRODUCTION TO MODERN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SERVICES

INTRODUCTION TO MODERN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SERVICES WHITE PAPER INTRODUCTION TO MODERN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SERVICES Randomization is fundamental to clinical trials it enables treatment group balance, eliminates selection bias and limits

More information

Secure Interim Analysis Data Access. Management with ACES. Eric J. Silva, Cytel, Inc. Steven Ketchum, Ph.D., Sunesis Pharmaceuticals

Secure Interim Analysis Data Access. Management with ACES. Eric J. Silva, Cytel, Inc. Steven Ketchum, Ph.D., Sunesis Pharmaceuticals Secure Interim Analysis Data Access and Automated DMC/DSMB Management with ACES Eric J. Silva, Cytel, Inc. Steven Ketchum, Ph.D., Sunesis Pharmaceuticals Introductions: Today s Speakers Eric J. Silva Manager,

More information

PAREXEL ACCESS MANAGED ACCESS PROGRAMS

PAREXEL ACCESS MANAGED ACCESS PROGRAMS PAREXEL ACCESS MANAGED ACCESS PROGRAMS Demands are increasing on biopharmaceutical companies developing treatments for unmet diseases to make them available to select patients even before the drug is labeled,

More information

Simulation and Implementation of Drug Supply Strategies

Simulation and Implementation of Drug Supply Strategies Simulation and Implementation of Drug Supply Strategies Ni$n R Patel, Chairman and CTO Presented by Jim Bolognese, Sr. Dir. Strategic Consul$ng Cytel, Inc. Evan Hahn, US RTSM Lead David Friend, Sr. Business

More information

Quality Assurance of Investigational Medicinal Products. Sue McKenzie PPQA (A)

Quality Assurance of Investigational Medicinal Products. Sue McKenzie PPQA (A) Quality Assurance of Investigational Medicinal Products Sue McKenzie PPQA (A) Agenda for Today IMP Regulations - CTD and Annex 13 Role of QP for IMP Challenges of IMP Manufacture for the QP IMP Regulations

More information

PAREXEL PARTNER PROGRAM. Broaden your reach with a partner you can trust

PAREXEL PARTNER PROGRAM. Broaden your reach with a partner you can trust PAREXEL PARTNER PROGRAM Broaden your reach with a partner you can trust YOUR JOURNEY. OUR MISSION. Combining technology and services to provide the right solution to help you and your clients succeed REGARDLESS

More information

DRUG ORDERING AND MAINTENANCE

DRUG ORDERING AND MAINTENANCE AND MAINTENANCE Disclaimer: Please note that the instructions provided in this chapter mainly apply to agents provided by the Pharmaceutical Management Branch (PMB), of Cancer Therapy Evaluation Program

More information

End-to-End Management of Clinical Trials Data

End-to-End Management of Clinical Trials Data End-to-End Management of Clinical Trials Data A Revolutionary Step Toward Supporting Clinical Trials Analysis Over the Next Decades of Clinical Research WHITE PAPER SAS White Paper Table of Contents Introduction....

More information

CTS East Coast. Increasing Agility and Innovation in the Clinical Supply Chain for Cost Optimization. Connect with us to connect with Asia

CTS East Coast. Increasing Agility and Innovation in the Clinical Supply Chain for Cost Optimization. Connect with us to connect with Asia Increasing Agility and Innovation in the Clinical Supply Chain for Cost Optimization Connect with us to connect with Asia CTS East Coast Oct 19 th, 2011 Philadelphia Introduction Zuellig Pharma Asia Pacific

More information

IMP Management and Accountability

IMP Management and Accountability This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document

More information

Pharmaceutical Development (Drug Substance & Drug Product) for Visceral Leishmaniasis candidate DNDI-6148

Pharmaceutical Development (Drug Substance & Drug Product) for Visceral Leishmaniasis candidate DNDI-6148 Request for Proposal Pharmaceutical Development (Drug Substance & Drug Product) for Visceral Leishmaniasis candidate DNDI-6148 Dated: October 12 th 2015 Page 1 Table of Contents 1. PURPOSE... 3 2. RFP

More information

Table of Contents. Presented by

Table of Contents. Presented by Table of Contents Presented by HighTech Business Decisions 3150 Almaden Expressway, Suite 222, San Jose, CA 95118 Tel: (408) 978-1035 Fax: (408) 978-8925 www.hightechdecisions.com May 2017 TABLE OF CONTENTS

More information

July 9. Course Catalog. Camstar Semiconductor Suite Release 6 CONFIDENTAL

July 9. Course Catalog. Camstar Semiconductor Suite Release 6 CONFIDENTAL July 9 Course Catalog 2015 Camstar Suite Release 6 CONFIDENTAL Contents General Information... 1 Available Training Camstar Suite v6... 2 Course Names and Descriptions... 3 Exploring Camstar Suite... 3

More information

SHOULD YOUR BARCODE LABELING SOLUTION BE FULLY INTEGRATED WITH YOUR BUSINESS SYSTEM?

SHOULD YOUR BARCODE LABELING SOLUTION BE FULLY INTEGRATED WITH YOUR BUSINESS SYSTEM? SHOULD YOUR BARCODE LABELING SOLUTION BE FULLY INTEGRATED WITH YOUR BUSINESS SYSTEM? B U S I N E S S T R A N S F O R M AT I O N T H R O U G H T O TA L S Y S T E M I N T E G R AT I O N TEKLYNX Americas

More information

The interface between Good Clinical Practice and Good Manufacturing Practice

The interface between Good Clinical Practice and Good Manufacturing Practice 1 The interface between Good Clinical Practice and Good Manufacturing Practice your partner in compliance 1 The interface between GCP and GMP Generally, studies are designed and planned by physicians who

More information

Volunteering for Clinical Trials

Volunteering for Clinical Trials Volunteering for Clinical Trials Volunteering for Clinical Trials When considering volunteering for a clinical trial, it is important to make an informed decision. Below are answers to frequently asked

More information

Sean Hobday. Senior Vice President, International and Strategic Accounts

Sean Hobday. Senior Vice President, International and Strategic Accounts Sean Hobday Senior Vice President, International and Strategic Accounts Global Services Platform Sean Hobday SVP Global Sales and Operations global services provides our global clients with a consistent

More information

DELMIA Apriso for A&D DELMIA Apriso 2017 Conceptual Design

DELMIA Apriso for A&D DELMIA Apriso 2017 Conceptual Design DELMIA Apriso for A&D DELMIA Apriso 2017 Conceptual Design 2016 Dassault Systèmes. Apriso, 3DEXPERIENCE, the Compass logo and the 3DS logo, CATIA, SOLIDWORKS, ENOVIA, DELMIA, SIMULIA, GEOVIA, EXALEAD,

More information

Recommendations for Strengthening the Investigator Site Community

Recommendations for Strengthening the Investigator Site Community Recommendations for Strengthening the Investigator Site Community October 2017 CTTI MISSION: To develop and drive adoption of practices that will increase the quality and efficiency of clinical trials

More information

Summary of Provisions in 21 st Century Cures Act (H.R. 6) as passed by full House of Representatives, July 10, 2015

Summary of Provisions in 21 st Century Cures Act (H.R. 6) as passed by full House of Representatives, July 10, 2015 Pediatric-Specific Provisions Summary of Provisions in 21 st Century Cures Act (H.R. 6) as passed by full House of Representatives, July 10, 2015 Requires the NIH to complete a strategic plan, and in the

More information

Digital Evolution in Life Sciences Supply Chain and Strategic Procurement Processes

Digital Evolution in Life Sciences Supply Chain and Strategic Procurement Processes SAP Ariba Solutions for Direct Spend Digital Evolution in Life Sciences Supply Chain and Strategic Procurement Processes Driving Innovation by Digitalizing and Virtualizing Supply Chain Collaboration 1

More information

CLINICAL TRIAL ENROLLMENT FORECASTING A WEB-BASED PERFORMANCE MANAGEMENT APPLICATION

CLINICAL TRIAL ENROLLMENT FORECASTING A WEB-BASED PERFORMANCE MANAGEMENT APPLICATION CLINICAL TRIAL ENROLLMENT FORECASTING A WEB-BASED PERFORMANCE MANAGEMENT APPLICATION BUSINESS VALUE GUIDE CLINICAL TRIAL ENROLLMENT FORECASTING CHALLENGES Patient enrollment is a major headache for life

More information

ISRCTN: EudraCT Number: Sponsor Protocol Number: UCL 08/0350. Pharmacy Manual

ISRCTN: EudraCT Number: Sponsor Protocol Number: UCL 08/0350. Pharmacy Manual The StAmP Trial: A Proof of Principle, double blind, Randomised Placebo-Controlled, Multi Centre Trial of Statins to Ameliorate Early Onset Pre-eclampsia. ISRCTN: 23410175 EudraCT Number: 2009-012968-13

More information

Vendor Selection: Identifying Effective Procedures & Strategies

Vendor Selection: Identifying Effective Procedures & Strategies Outsourcing Clinical Trials Canada 15 th November 2012 Vendor Selection: Identifying Effective Procedures & Strategies John S Andrews PhD President and CSO, NeurAxon Inc President, Ketogen Inc CSO, Talon

More information

LINEAR PROGRAMMING APPROACHES TO AGGREGATE PLANNING. Linear programming is suitable to determine the best aggregate plan.

LINEAR PROGRAMMING APPROACHES TO AGGREGATE PLANNING. Linear programming is suitable to determine the best aggregate plan. LINEAR PROGRAMMING APPROACHES TO AGGREGATE PLANNING Linear programming is suitable to determine the best aggregate plan. Recall that linear programming assumes all variables are continuously divisible.

More information

Global Life Sciences BPO Market to be Worth USD 596 Billion by 2019: Transparency Market Research

Global Life Sciences BPO Market to be Worth USD 596 Billion by 2019: Transparency Market Research Transparency Market Research Global Life Sciences BPO Market to be Worth USD 596 Billion by 2019: Transparency Market Research Buy Now Request Sample Published Date: April 2014 Single User License: US

More information

KNOWLEDGE BRIEF. MIC Customs Solutions Is Recognized As the Technology Leader in the Global GTM Market by Quadrant Knowledge Solutions

KNOWLEDGE BRIEF. MIC Customs Solutions Is Recognized As the Technology Leader in the Global GTM Market by Quadrant Knowledge Solutions KNOWLEDGE BRIEF MIC Customs Solutions Is Recognized As the Technology Leader in the Global GTM Market by Quadrant Knowledge Solutions KNOWLEDGE BRIEF BY MIC Customs Solutions Is Recognized As the Technology

More information

Introduction to Clinical Research

Introduction to Clinical Research Introduction to Clinical Research What is Clinical Research? Clinical research is medical research that involves people like you. People volunteer to participate in carefully conducted investigations that

More information

global clinical trials. integrated solutions. reduced timelines.

global clinical trials. integrated solutions. reduced timelines. global clinical trials. integrated solutions. reduced timelines. clinical supply DEVELOPMENT DELIVERY SUPPLY As a worldwide clinical supply services leader, Catalent has the scale, expertise, innovative

More information

CRO partner in Rx/CDx Co-Development

CRO partner in Rx/CDx Co-Development CRO partner in Rx/CDx Co-Development DEDICATED DIALOGUE A sponsored roundtable discussion published in Pharmaceutical Executive Two Covance executives discuss a CRO s role in supporting Companion Diagnostics

More information

IND Drug Log Guidelines

IND Drug Log Guidelines 9/24/2009 IND Drug Log Guidelines 1) An NCI DARF (Drug Accountability Record Form) should be kept on each strength of investigational drug. An investigational drug is considered to be any drug (including

More information

PRIMARY CARE OPERATIONAL GUIDELINES

PRIMARY CARE OPERATIONAL GUIDELINES 1 of 8 1. INTENT To provide direction regarding a standard and consistent approach for the planning and set-up of a within all WRHA Primary Care Direct Operated and Quick Care Clinics To assist in identifying

More information

Dynamic Simulation and Supply Chain Management

Dynamic Simulation and Supply Chain Management Dynamic Simulation and Supply Chain Management White Paper Abstract This paper briefly discusses how dynamic computer simulation can be applied within the field of supply chain management to diagnose problems

More information

New Cardinal Health (Post-Spin)

New Cardinal Health (Post-Spin) New Cardinal Health (Post-Spin) George Barrett Vice Chairman and Chief Executive Officer Healthcare Supply Chain Services and Chief Executive Officer Cardinal Health, Inc. (post-spin) January 14, 2009

More information

At the Heart of Connected Manufacturing

At the Heart of Connected Manufacturing www.niit-tech.com At the Heart of Connected Manufacturing Transforming Manufacturing Operations to Drive Agility and Profitability The success of the new manufacturing network hinges on the agility of

More information

A High-Touch Approach to Improving Patient Access. Using field support to navigate reimbursement challenges

A High-Touch Approach to Improving Patient Access. Using field support to navigate reimbursement challenges A High-Touch Approach to Improving Patient Access Using field support to navigate reimbursement challenges For the brand and reimbursement teams who must develop commercial strategies for the biopharmaceutical

More information

Oracle Buys ClearTrial Adds Leading Cloud-based Clinical Trial Operations and Analytics Applications to the Oracle Health Sciences Suite

Oracle Buys ClearTrial Adds Leading Cloud-based Clinical Trial Operations and Analytics Applications to the Oracle Health Sciences Suite Oracle Buys ClearTrial Adds Leading Cloud-based Clinical Trial Operations and Analytics Applications to the Oracle Health Sciences Suite April 12, 2012 Oracle is currently reviewing

More information

Planning of Application

Planning of Application 2016 Good Registration Management Regulatory Science Center of Excellence Pilot Workshop Planning of Application Moderator: Speaker: Jin Shun, AbbVie Thean Soo Lo, J&J Sannie Chong, Roche Agenda 10:00~10:05

More information

REQUEST FOR AUTHORISATION TO THE COMPETENT AUTHORITY: REQUEST FOR OPINION OF THE ETHICS COMMITTEE:

REQUEST FOR AUTHORISATION TO THE COMPETENT AUTHORITY: REQUEST FOR OPINION OF THE ETHICS COMMITTEE: Annex 1: Clinical trial Application Form REQUEST FOR AUTHORISATION OF A CLINICAL TRIAL ON A MEDICINAL PRODUCT FOR HUMAN USE TO THE COMPETENT AUTHORITIES AND FOR OPINION OF THE ETHICS COMMITTEES IN THE

More information

PAREXEL STRATEGIC PARTNERSHIPS. Optimizing relationships for shorter time to market

PAREXEL STRATEGIC PARTNERSHIPS. Optimizing relationships for shorter time to market PAREXEL STRATEGIC PARTNERSHIPS Optimizing relationships for shorter time to market YOUR JOURNEY. OUR MISSION. Delivering a more collaborative and operationally efficient relationship so you can reach your

More information

CTSA Trial Innovation Network Early Vision & Goals MONICA SHAH, MD DIRECTOR, TRIAL INNOVATION NETWORK

CTSA Trial Innovation Network Early Vision & Goals MONICA SHAH, MD DIRECTOR, TRIAL INNOVATION NETWORK CTSA Trial Innovation Network Early Vision & Goals MONICA SHAH, MD DIRECTOR, TRIAL INNOVATION NETWORK What Do They Have in Common? Hammer M. Harvard Business Review, 2004. What Do They Have in Common?

More information

19 th Annual Clinical Trial Supply Europe Conference

19 th Annual Clinical Trial Supply Europe Conference 19 th Annual Clinical Trial Supply Europe Conference March 14 th -15 th 2018 Milan, Italy 2018 Speaking Faculty Henk Dieteren, Associate Director, Clinical Supply Logistics Expert, Grunenthal Tania Snioch,

More information

Global Contract Research Organization (CRO) Market: Size, Trends & Forecasts ( ) November 2017

Global Contract Research Organization (CRO) Market: Size, Trends & Forecasts ( ) November 2017 Global Contract Research Organization (CRO) Market: Size, Trends & Forecasts (2017-2021) November 2017 Global Contract Research Organization (CRO) Market : Coverage Executive Summary and Scope Introduction/Market

More information

WHITE PAPER. Solutions to Global Pharmaceutical Supply Chain Challenges

WHITE PAPER. Solutions to Global Pharmaceutical Supply Chain Challenges WHITE PAPER Solutions to Global Pharmaceutical Supply Chain Challenges Solutions to Global Pharmaceutical Supply Chain Challenges Find out how a contract packaging company can deliver the expertise and

More information

Good Clinical Practice (GCP) & Clinical Trial Registries

Good Clinical Practice (GCP) & Clinical Trial Registries Good Clinical Practice (GCP) & Clinical Trial Registries The Fifth Annual Pharmaceutical Regulatory and Compliance Congress and Best Practice Forum November 14-17, 2004 Kate Maloney, RN, MS, CPHQ Manager,

More information

19 th Annual Clinical Trial Supply Europe Conference

19 th Annual Clinical Trial Supply Europe Conference 19 th Annual Clinical Trial Supply Europe Conference March 14 th -15 th 2018 Milan, Italy 2018 Speaking Faculty Henk Dieteren, Associate Director, Clinical Supply Logistics Expert, Grunenthal Tania Snioch,

More information

Role of IT. in a Supply Chain. Information Technology. in a Supply Chain. Use of Information

Role of IT. in a Supply Chain. Information Technology. in a Supply Chain. Use of Information Information Technology in a Supply Chain Role of IT Information is the driver that serves as the glue to create a coordinated supply chain Information must have the following characteristics to be useful:

More information

Q&A on ICH Q7 Good Manufacturing Practice Questions and Answers Document

Q&A on ICH Q7 Good Manufacturing Practice Questions and Answers Document Q&A on ICH Q7 Good Manufacturing Practice Questions and Answers Document March 2017 International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use 1 ICH Q7 - Questions

More information

Human Research Protection Program Good Clinical Practice Guidance for Investigators Regulatory File Essential Documents

Human Research Protection Program Good Clinical Practice Guidance for Investigators Regulatory File Essential Documents Guidance for s Regulatory File Essential s All principal investigators must maintain a regulatory binder or file system, which contains all study documentation. These records may be reviewed at the time

More information

Enabling faster insights to improve clinical trial efficiency and quality

Enabling faster insights to improve clinical trial efficiency and quality Enabling faster insights to improve clinical trial efficiency and quality Clarity, understanding and confidence Every clinical trial has moments when decisive action is needed to set the course for a

More information

Supplier Guide Book. Collaborate, perform, grow together

Supplier Guide Book. Collaborate, perform, grow together Supplier Guide Book Collaborate, perform, grow together Message from our Chief Purchasing Officer Dear Supplier, DK Singh CPO Schneider Electric We are pleased to publish the Schneider Electric Supplier

More information

CHALLENGES OF GLOBAL CLINICAL TRIAL SUPPLY SOURCING SOME SPECIFICS FOR EMERGING MARKETS

CHALLENGES OF GLOBAL CLINICAL TRIAL SUPPLY SOURCING SOME SPECIFICS FOR EMERGING MARKETS Clinical Trial Supply 28 th 29 th October 2014 Princeton, NJ - USA CHALLENGES OF GLOBAL CLINICAL TRIAL SUPPLY SOURCING SOME SPECIFICS FOR EMERGING MARKETS 1 Agenda The challenges associated with various

More information

Early Development Best Practices for Stability- Regulatory Perspective

Early Development Best Practices for Stability- Regulatory Perspective Early Development Best Practices for Stability- Regulatory Perspective IQ Workshop, Feb. 4-5, 2014, Washington, D.C. Ramesh Sood, Ph.D. Division Director (Acting) Office of New Drug Quality Assessment

More information

Developing a European First-in-Human Study: Three Key Decisions

Developing a European First-in-Human Study: Three Key Decisions Developing a European First-in-Human Study: Three Key Decisions By Nicole Feist, BA Clinical A key step in the translational medicine benchtop to bedside process model is the move from research and preclinical

More information

University Health Network UDI Capture Work Group Case Study

University Health Network UDI Capture Work Group Case Study LEARNING UDI COMMUNITY University Health Network UDI Capture Work Group Case Study WWW.AHRMM.ORG / LUC WORK GROUP TITLE: UDI Capture Work Group CASE STUDY PARTICIPANTS Wendy Watson, OR Supply Chain Manager

More information

Corporate Brochure. Elevate Your Flexible Workforce Management and Services Procurement

Corporate Brochure. Elevate Your Flexible Workforce Management and Services Procurement Corporate Brochure Elevate Your Flexible Workforce Management and Services Procurement Table of Contents SAP FIELDGLASS: POWERING YOUR FLEXIBLE WORKFORCE 4 IDENTIFYING YOUR CHALLENGES 6 DELIVERING YOUR

More information

GUIDANCE FOR INDUSTRY ON FIXED DOSE COMBINATIONS (FDCs)

GUIDANCE FOR INDUSTRY ON FIXED DOSE COMBINATIONS (FDCs) GUIDANCE FOR INDUSTRY ON FIXED DOSE COMBINATIONS (FDCs) DRAFT GUIDANCE This guidance document is for feedback purposes only Comments and suggestions regarding this draft document should be submitted within

More information

The Process Diagnostic. How to optimize the technology transfer and the development

The Process Diagnostic. How to optimize the technology transfer and the development The Process Diagnostic How to optimize the technology transfer and the development a does the on Introduction A critical aspect of industrialization is development. It is all about how to industrialize

More information

SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL STUDY PROTOCOL CHAPTER 14 REVISED: OCTOBER 2015

SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL STUDY PROTOCOL CHAPTER 14 REVISED: OCTOBER 2015 THE STUDY PROTOCOL The study protocol is a written document detailing how a clinical trial is conducted. The elements of a protocol include: 1. Trial design and organization; 2. Study objectives; 3. Background

More information

The Aptuit Center for Drug Discovery & Development Verona, Italy

The Aptuit Center for Drug Discovery & Development Verona, Italy The Aptuit Center for Drug Discovery & Development Verona, Italy 2 The Aptuit Center for Drug Discovery & Development Verona, Italy Aptuit in Verona: uncommon expertise, exceptional results A knowledgeable

More information

THE DOD/FDA SHELF LIFE EXTENSION PROGRAM TO EXTEND THE SHELF LIFE OF CRITICAL STOCKPILES OF MEDICAL MATERIEL FOR THE FEDERAL GOVERNMENT

THE DOD/FDA SHELF LIFE EXTENSION PROGRAM TO EXTEND THE SHELF LIFE OF CRITICAL STOCKPILES OF MEDICAL MATERIEL FOR THE FEDERAL GOVERNMENT THE DOD/FDA SHELF LIFE EXTENSION PROGRAM TO EXTEND THE SHELF LIFE OF CRITICAL STOCKPILES OF MEDICAL MATERIEL FOR THE FEDERAL GOVERNMENT Introduction To assure preparedness for war or other contingencies,

More information

2018 Confirmed Speakers

2018 Confirmed Speakers The leading clinical trial supply series delivering localised content to key biopharma clusters 2018 Confirmed Speakers Eyal Ron, Chief Technology Officer, Gelesis Michael Sparozic, Trial Supplies Operation

More information

EFPIA layperson summary Principles that apply to Clinical Trial Transparency. Antonio Ferrari (Chiesi) & Solange Rohou (AZ)

EFPIA layperson summary Principles that apply to Clinical Trial Transparency. Antonio Ferrari (Chiesi) & Solange Rohou (AZ) EFPIA layperson summary Principles that apply to Clinical Trial Transparency. Antonio Ferrari (Chiesi) & Solange Rohou (AZ) Disclaimer I am an employee of Chiesi Farmaceutici s.p.a (Head of Clinical Safety

More information

Expanded Access. to Investigational Drugs & Biologics. for Treatment Use

Expanded Access. to Investigational Drugs & Biologics. for Treatment Use SJMHS Research Compliance Office Guidance Document Expanded Access to Investigational Drugs & Biologics for Treatment Use May 2015 1 Expanded Access to Investigational Drugs & Biologics for Treatment Use

More information

The Integrated Support and Assurance Process (ISAP): detailed guidance on assuring novel and complex contracts

The Integrated Support and Assurance Process (ISAP): detailed guidance on assuring novel and complex contracts The Integrated Support and Assurance Process (ISAP): detailed guidance on assuring novel and complex contracts Part C: Guidance for NHS trusts and NHS foundation trusts Published by NHS England and NHS

More information

Document Reuse: Theory and Practice

Document Reuse: Theory and Practice Document Reuse: Theory and Practice Peggy Boe, RN Sr. Director, Medical Writing Image Solutions, Inc (ISI) Company logo here Best Practice: Single Sourcing Creating reusable text and information Requires

More information

Business Process Modeling for Supply Chain Transformation

Business Process Modeling for Supply Chain Transformation Business Process Modeling for Supply Chain Transformation Neha Jain, CPIM Janice Gullo, CFPIM, CSCP Neha Jain Neha Jain is a Business Process Consultant in DuPont. Her responsibilities include process

More information

Industry Perspective on Manufacturing in Early Development

Industry Perspective on Manufacturing in Early Development Industry Perspective on Manufacturing in Early Development IQ Workshop, Feb 4-5, 2014, Washington, D.C. Eric Schmitt AbbVie IQ Drug Product Manufacturing Working Group August 2012 issue of Pharmaceutical

More information

Program Management Professional (PgMP)

Program Management Professional (PgMP) Program Management Professional (PgMP) E X A M I N AT I O N CO N T E N T O U T L I N E Project Management Institute Program Management Professional (PgMP ) Examination Content Outline April 2011 Published

More information

MICROSOFT DYNAMICS GP. Product Capabilities and Business Ready Licensing Module Guide. Solutions

MICROSOFT DYNAMICS GP. Product Capabilities and Business Ready Licensing Module Guide. Solutions MICROSOFT DYNAMICS GP Product Capabilities and Business Ready Licensing Module Guide Solutions Become a Dynamic Business with Microsoft Dynamics GP For more than 25 years, Microsoft Dynamics GP has delivered

More information

An Industry Perspective: Reducing the Complexity and Impact of Regulatory Changes in Latin America

An Industry Perspective: Reducing the Complexity and Impact of Regulatory Changes in Latin America An Industry Perspective: Reducing the Complexity and Impact of Regulatory Changes in Latin America SPEAKERS: Janett Mugaburu-Richards, M.S. Pfizer Inc. Kavita Ramalingam Iyer, Ph.D Merck & Co., Inc. Contents

More information

GUIDELINES FOR THE USE OF CONTROLLED SUBSTANCES IN RESEARCH MICHIGAN STATE UNIVERSITY ENVIRONMENTAL HEALTH AND SAFETY

GUIDELINES FOR THE USE OF CONTROLLED SUBSTANCES IN RESEARCH MICHIGAN STATE UNIVERSITY ENVIRONMENTAL HEALTH AND SAFETY GUIDELINES FOR THE USE OF CONTROLLED SUBSTANCES IN RESEARCH MICHIGAN STATE UNIVERSITY ENVIRONMENTAL HEALTH AND SAFETY REVISION 4.2018 INTRODUCTION In conducting research with controlled substances, University

More information

A White Paper by Exact Software ERP-II: Making ERP Deliver On Its Promise to the Enterprise. Business Unified

A White Paper by Exact Software ERP-II: Making ERP Deliver On Its Promise to the Enterprise. Business Unified A White Paper by Exact Software ERP-II: Making ERP Deliver On Its Promise to the Enterprise Business Unified Introduction Conventional ERP has fallen short in a few areas that are critical to today s business

More information

ORACLE RESPONSYS PROFESSIONAL SERVICES DESCRIPTIONS

ORACLE RESPONSYS PROFESSIONAL SERVICES DESCRIPTIONS ORACLE RESPONSYS PROFESSIONAL SERVICES DESCRIPTIONS (January 25, 2018) RESPONSYS CONSULTING SERVICES PACKAGES... 3 Responsys Basic SmartStart Implementation Service Remote... 3 Responsys Premium SmartStart

More information

SAP Leonardo Live. North America

SAP Leonardo Live. North America SAP Leonardo Live North America TITLE Cargill: Connecting the Supply Chain with Digital Business Planning Eric Johnson Vice President Operations and Supply Chain www.cargill.com CONFIDENTIAL. This document

More information

How to rescue a clinical trial

How to rescue a clinical trial How to rescue a clinical trial Clinical trial conduct is demanding and rigorous, especially in orphan indications where patient populations are small. Even well-qualified, specifically selected Contract

More information

Predictive Modelling of Recruitment and Drug Supply in Multicenter Clinical Trials

Predictive Modelling of Recruitment and Drug Supply in Multicenter Clinical Trials Biopharmaceutical Section JSM 009 Predictive Modelling of Recruitment and Drug Supply in Multicenter Clinical Trials Vladimir Anisimov Abstract Patient recruitment and drug supply planning are the biggest

More information

Innovation & Automation in Accounts Payable: Dramatic Shifts are Occurring, Is your Company Innovating Ahead of the Curve or Caught in Neutral?

Innovation & Automation in Accounts Payable: Dramatic Shifts are Occurring, Is your Company Innovating Ahead of the Curve or Caught in Neutral? Innovation & Automation in Accounts Payable: Dramatic Shifts are Occurring, Is your Company Innovating Ahead of the Curve or Caught in Neutral? 5/31/2016 The Accounts Payable & Procure-To-Pay Conference

More information

Experience with Adaptive Dose-Ranging Studies in Early Clinical Development

Experience with Adaptive Dose-Ranging Studies in Early Clinical Development Experience with Adaptive Dose-Ranging Studies in Early Clinical Development Judith Quinlan MSc Vice President Adaptive Trials Cytel Inc. judith.quinlan@cytel.com Thanks to members of the PhRMA Adaptive

More information

CV Lars Jakob Rasmussen

CV Lars Jakob Rasmussen CV Lars Jakob Rasmussen Contact Information Name: Lars Jakob Rasmussen Address: Im Kugelfang 32, 4102 Binningen, Switzerland Phone: +41 61 331 2566 Mobil: +41 79 837 5996 Mail: Lars_Jakob@amsted.dk Personal

More information

TITLE: Research Pharmacy Standard Policy SOP #: INV-100 Page: 1 of 5 Effective Date: 8/31/17

TITLE: Research Pharmacy Standard Policy SOP #: INV-100 Page: 1 of 5 Effective Date: 8/31/17 SOP #: INV-100 Page: 1 of 5 1. POLICY STATEMENT: DF/HCC research pharmacies follow a standard set of policy requirements for clinical trials. 2. BACKGROUND: None 3. RESPONSIBLE PERSONNEL: 3.1. Research

More information

Welcome to the ITS PMO! Start a new IT Project

Welcome to the ITS PMO! Start a new IT Project Welcome to the ITS PMO! Start a new IT Project WELCOME TO THE ITS PORTFOLIO MANAGEMENT OFFICE What is the PMO Office? Information Technology Services (ITS) has recently developed a Portfolio Management

More information

How Logistics Enables the Healthcare Revolution. Richard Holmes Managing Director of Polar Speed Distribution Ltd, a UPS company

How Logistics Enables the Healthcare Revolution. Richard Holmes Managing Director of Polar Speed Distribution Ltd, a UPS company How Logistics Enables the Healthcare Revolution Richard Holmes Managing Director of Polar Speed Distribution Ltd, a UPS company Introduction There is a revolution taking place in healthcare delivery. Patient-centred

More information

Course Outline TO TRAIN

Course Outline TO TRAIN 1300 86 87246 1300 TO TRAIN 80309 - Microsoft Dynamics AX 2012 Process Manufacturing Production and Logistics General Description This three-day instructor-led course provides learners with knowledge about

More information

TOTAL REWARDS AT NESTLÉ: MORE THAN JUST A POLICY

TOTAL REWARDS AT NESTLÉ: MORE THAN JUST A POLICY TOTAL REWARDS AT NESTLÉ: MORE THAN JUST A POLICY Operating in more than 190 countries and with over 300,000 employees, Nestlé is one of the biggest multinational corporations in the world. Group sales

More information

EFPIA-PHRMA PRINCIPLES FOR RESPONSIBLE CLINICAL TRIAL DATA SHARING REPORT ON THE 2016 MEMBER COMPANY SURVEY

EFPIA-PHRMA PRINCIPLES FOR RESPONSIBLE CLINICAL TRIAL DATA SHARING REPORT ON THE 2016 MEMBER COMPANY SURVEY EFPIA-PHRMA PRINCIPLES FOR RESPONSIBLE CLINICAL TRIAL DATA SHARING REPORT ON THE 2016 MEMBER COMPANY SURVEY PREAMBLE The European Federation of Pharmaceutical Industries and Associations (EFPIA) and the

More information

Partner with the Global Leader in Drug Delivery Systems

Partner with the Global Leader in Drug Delivery Systems 3M DRUG DELIVERY SYSTEMS Partner with the Global Leader in Drug Delivery Systems Northridge, CA, USA Manufacturing Facility Experts at Commercializing Innovation 3M: Transforming New Ideas into Thousands

More information

Challenges of Analytical Method Transfer in the Pharmaceutical Industry

Challenges of Analytical Method Transfer in the Pharmaceutical Industry Challenges of Analytical Method Transfer in the Pharmaceutical Industry White Paper Author: Steve Alley, Technical Specialist 1 Contents Introduction 2 Method Transfer Team 3 Identify Methods 4 Gap Analysis

More information

Brexit Guidance for Stakeholders Human and veterinary medicines

Brexit Guidance for Stakeholders Human and veterinary medicines Brexit Guidance for Stakeholders Human and veterinary medicines DATE: 03 JANUARY 2018 V.2 This guide does not purport to be an interpretation of law and/or regulations. The content provided is subject

More information

CHINA. Australia - China Life Science Summit. . Bio & Pharma Logistics

CHINA. Australia - China Life Science Summit. . Bio & Pharma Logistics CHINA. Bio & Pharma Logistics Andrew McDonald Operations Director, Asia Pacific Melbourne, Australia, 27th March 2013 Australia - China Life Science Summit Responsibilities Who takes responsibility on

More information

Keys to a successful WAREHOUSE MANAGEMENT SYSTEM (WMS)

Keys to a successful WAREHOUSE MANAGEMENT SYSTEM (WMS) Keys to a successful WAREHOUSE MANAGEMENT SYSTEM (WMS) www.lidd.ca table of contents Understand How to Evaluate your Current WMS vs Other Solutions on the Market...3 W stands for Warehouse...4 M stands

More information

VOLUME 4 Good manufacturing practices ANNEX 13 Manufacture of investigational medicinal products JULY 2003

VOLUME 4 Good manufacturing practices ANNEX 13 Manufacture of investigational medicinal products JULY 2003 EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market : management & legislation for consumer goods Pharmaceuticals : regulatory framework and market authorisations Brussels, F2/BL D(2003) Revision

More information

Business Process Improvement (BPI) Shared Service

Business Process Improvement (BPI) Shared Service Business Process Improvement (BPI) Shared Service Monthly Report for October 2016 Data as of 10/13/2016 This report intends to provide a summary of the progress and status of the projects that have been

More information

Expanded Access and the Individual Patient IND

Expanded Access and the Individual Patient IND Expanded Access and the Individual Patient IND Research Wednesdays April 26, 2017 Erika Segear Johnson, PhD, RAC Associate Director of Regulatory Affairs Office of Regulatory Affairs and Quality Office

More information

Decoding Phase II Clinical Trial Terminations

Decoding Phase II Clinical Trial Terminations Decoding Phase II Clinical Trial Terminations Why Phase II trials are terminated and what can be done to improve Phase II success rates - the most critical inflection point for clinical development Subha

More information